QI
LGND icon

QS Investors’s Ligand Pharmaceuticals LGND Stock Holding History

QS Investors’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-5,090
Closed -$316K – 1228
2020
Q4 		$316K Hold
5,090
– – ﹤0.01% 971
2020
Q3 		$303K Sell
5,090
-16,334
-76% -$1.11M ﹤0.01% 916
2020
Q2 		$1.5M Hold
21,424
– – 0.02% 597
2020
Q1 		$972K Buy
21,424
+120
+0.6% +$6.8K 0.02% 669
2019
Q4 		$1.39M Sell
21,304
-160
-0.7% -$10.7K 0.01% 692
2019
Q3 		$1.33M Hold
21,464
– – 0.01% 694
2019
Q2 		$1.53M Sell
21,464
-513
-2% -$37.8K 0.02% 673
2019
Q1 		$1.72M Buy
21,977
+21,171
+2,627% +$1.6M 0.02% 664
2018
Q4 		$69K Hold
806
– – ﹤0.01% 1407
2018
Q3 		$138K Hold
806
– – ﹤0.01% 1310
2018
Q2 		$104K Hold
806
– – ﹤0.01% 1397
2018
Q1 		$83K Hold
806
– – ﹤0.01% 1406
2017
Q4 		$69K Hold
806
– – ﹤0.01% 1430
2017
Q3 		$68K Hold
806
– – ﹤0.01% 1459
2017
Q2 		$61K Hold
806
– – ﹤0.01% 1471
2017
Q1 		$53K Buy
806
+801
+16,020% +$52.7K ﹤0.01% 1495
2016
Q4 		$1K Hold
5
– – ﹤0.01% 1656
2016
Q3 		$1K Buy
5
+2
+67% +$147 ﹤0.01% 1641
2016
Q2 		$1K Sell
3
-5
-63% -$371 ﹤0.01% 1680
2016
Q1 		$1K Buy
8
+5
+167% +$304 ﹤0.01% 1675
2015
Q4 		$1K Buy
+3
New +$185 ﹤0.01% 1701

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

QS Investors's LGND Position: Q1 2021 in Review

QS Investors sold out of Ligand Pharmaceuticals (LGND) in Q1 2021, closing a stake of 5,090 shares — an estimated $316K sold.

QS Investors first reported a position in LGND in Q4 2015 and held it in 21 quarters. The position peaked at $1.72M in Q1 2019. 228 funds tracked by Wall St. Rank hold LGND as of Q1 2021.

  • QS Investors reported no remaining Ligand Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • QS Investors sold 5,090 Ligand Pharmaceuticals shares in Q1 2021, an estimated $316K.
  • QS Investors first reported a position in Ligand Pharmaceuticals in Q4 2015 and held it in 21 quarters.
  • QS Investors's Ligand Pharmaceuticals position peaked at $1.72M in Q1 2019.
  • 228 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2021.

Based on QS Investors's 13F filing for Q1 2021, filed 13 May 2021.